Ayr Wellness Inc.
AYRWFdata completeness 100%6 fiscal years on fileAyr Wellness Inc. earns about -6% on invested capital, and has bought back 100% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|
| Revenue | $155.1M1 | $357.6M2 | $421.4M3 | $463.6M4 | $463.6M4 |
| Net income | −$24.6M5 | −$17M6 | −$245.5M7 | −$272.4M8 | −$359.3M8 |
| Operating cash flow | — | — | −$34.2M9 | $27.2M10 | $9.63M10 |
| Capital expenditure | $14.4M11 | $91.6M12 | $58.8M13 | $27.7M14 | $17.7M14 |
| Free cash flow (derived) | — | — | −$93M9 | −$532,00010 | −$8.08M10 |
| Total debt | — | — | $176.8M15 | $434.5M16 | $820.9M16 |
| Cash & equivalents | $127.2M17 | $150.1M18 | $76.8M19 | $50.8M19 | $35.5M20 |
| Diluted shares | 28.9M | 57,329 | 68,635 | 74,096 | 110,832 |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $34,243.36 of net worth that earned you −$32,419.25 and generated −$729.39 of cash last year, against $74,071.39 of debt.
It earned an average -6% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 100% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 364% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 40-F · period ending 2020-12-31 · accession 0001104659-22-040047 (Revenue)
- 40-F · period ending 2021-12-31 · accession 0001104659-23-030769 (Revenue)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 40-F · period ending 2023-12-31 · accession 0001104659-25-026765 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 40-F · period ending 2020-12-31 · accession 0001104659-22-040047 (ProfitLoss)
- 40-F · period ending 2021-12-31 · accession 0001104659-23-030769 (ProfitLossAttributableToOwnersOfParent)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (NetIncomeLoss)
- 40-F · period ending 2023-12-31 · accession 0001104659-25-026765 (NetIncomeLoss)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (NetCashProvidedByUsedInOperatingActivities)
- 40-F · period ending 2023-12-31 · accession 0001104659-25-026765 (NetCashProvidedByUsedInOperatingActivities)
- 40-F · period ending 2020-12-31 · accession 0001104659-22-040047 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 40-F · period ending 2021-12-31 · accession 0001104659-23-030769 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (PaymentsToAcquirePropertyPlantAndEquipment)
- 40-F · period ending 2023-12-31 · accession 0001104659-25-026765 (PaymentsToAcquirePropertyPlantAndEquipment)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (LongTermDebtNoncurrent)
- 40-F · period ending 2023-12-31 · accession 0001104659-25-026765 (LongTermDebtNoncurrent)
- 40-F · period ending 2020-12-31 · accession 0001104659-23-030769 (CashAndCashEquivalents)
- 40-F · period ending 2021-12-31 · accession 0001104659-24-033746 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
- 40-F · period ending 2022-12-31 · accession 0001104659-24-033746 (CashAndCashEquivalentsAtCarryingValue)
- 40-F · period ending 2024-12-31 · accession 0001104659-25-026765 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)